there was a study , published in the journal (NEUROLOGY) IN JUNE
1995 RE: PARKINSONS DISEASE PATIIENTS GIVEN
GANGLIOSIDE G M 1.
THERE WERE STUDIES PUBLISHED IN VARIOUS NEUROLOGIC AL JOURNALS
PUBLISHED IN 1991 AND 1992 OF MONKEYS MADE PARKONSONIAN BY BEING
INJECTED BY
MPTP AND THEN HAVING THE P.D. SYMPTOMS REVERSED BY
GIVEN INJECTIONS OF GANGLIOSIDE G.M.1..
DR. STEVE SCHNEIDER OF HAHNEMANN UNIVERSITY IN PHILADELPHIA,
PA. ( TELEPHONE 215 762 3066 ) IS CURRENTLY RECRUTING PATIENTS FOR A DOUBLE
BLIND TRIAL OF GANGLIOSIDE G M 1 ALSO KNOWN AS SYGEN.
THIS IS HIS SECOND HUMAN TRIAL OF PATIENTS
GIVEN G M 1. THE FIRST WAS COMPLETED IN 1994.
THE GM1 WAS WELL TOLERATED AND " MANY FUN-
CTIONAL IMPROVEMENTS WERE PRESENT IN PATIENTS
AFTER 4 TO 8 WEEKS."
FRED ZIESS
212 348 5335
120 EAST 89 ST.
NEW YOK CITY N.Y. 10128
